Market research
PME.AU Pro Medicus Limited
AU AUD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 21B
- P/E ratio
- 78.11
- Analyst target
- 202.608
- Dividend yield
- 0.3%
- Beta
- 0.56
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- AU000000PME8
- Market cap
- 21B
- P/E ratio
- 78.11
- Analyst target
- 202.608
- Dividend yield
- 0.3%
- Beta
- 0.56
About
About Pro Medicus Limited
Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Research context
Pro Medicus Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the PME.AU discussion.
5 years, 6 months ago
Pro Medicus Limited is currently in a long term uptrend where the price is trading 41.4% above its 200 day moving average.
From a valuation standpoint, the stock is 70.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 77.1.
Pro Medicus Limited's total revenue rose by 7.8% to $32M since the same quarter in the previous year.
Its net income has increased by 12.4% to $14M since the same quarter in the previous year.
Finally, its free cash flow grew by 89.4% to $8M since the same quarter in the previous year.
Based on the above factors, Pro Medicus Limited gets an overall score of 5/5.